Copyright © 2012 Prasanna B. Galhena et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. J. W. Grisham, “Interspecies comparison of liver carcinogenesis: implications for cancer risk assessment,” Carcinogenesis, vol. 18, no. 1, pp. 59–81, 1997. View at Publisher · View at Google Scholar · View at Scopus
2. H. Tsukuma, T. Hiyama, S. Tanaka et al., “Risk factors for hepatocellular carcinoma among patients with chronic liver disease,” New England Journal of Medicine, vol. 328, no. 25, pp. 1797–1801, 1993. View at Publisher · View at Google Scholar · View at Scopus
3. Y. Nakamoto, L. G. Guidotti, C. V. Kuhlen, P. Fowler, and F. V. Chisari, “Immune pathogenesis of hepatocellular carcinoma,” Journal of Experimental Medicine, vol. 188, no. 2, pp. 341–350, 1998. View at Publisher · View at Google Scholar · View at Scopus
4. Y. Nakamoto, S. Kaneko, H. Fan et al., “Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-Fas ligand antibody therapy,” Journal of Experimental Medicine, vol. 196, no. 8, pp. 1105–1111, 2002. View at Publisher · View at Google Scholar · View at Scopus
5. D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Google Scholar · View at Scopus
6. M. H. Pan, G. Chai, and C. T. Ho, “Food bioactives, apoptosis, and cancer,” Molecular Nutrition & Food Research, vol. 52, pp. 43–52, 2008. View at Publisher · View at Google Scholar
7. E. Pikarsky, R. M. Porat, I. Stein et al., “NF-κB functions as a tumour promoter in inflammation-associated cancer,” Nature, vol. 431, no. 7007, pp. 461–466, 2004. View at Publisher · View at Google Scholar · View at Scopus
8. H. W. Sharma and R. Narayanan, “The NF-κB transcription factor in oncogenesis,” Anticancer Research, vol. 16, no. 2, pp. 589–596, 1996. View at Google Scholar · View at Scopus
9. K. G. Waddick and F. M. Uckun, “Innovative treatment programs against cancer: II. Nuclear factor-κB (NF-κB) as a molecular target,” Biochemical Pharmacology, vol. 57, no. 1, pp. 9–17, 1999. View at Publisher · View at Google Scholar · View at Scopus
10. H. Chien-Fu, L. Shih-Shen, L. Pao-Hsin, S. C. Young, and C. C. Yang, “The immunopharmaceutical effects and mechanisms of herb medicine,” Cellular and Molecular Immunology, vol. 5, no. 1, pp. 23–31, 2008. View at Publisher · View at Google Scholar · View at Scopus
11. T. B. Al-Naggar, M. P. Gómez-Serranillos, M. E. Carretero, and A. M. Villar, “Neuropharmacological activity of Nigella sativa L. extracts,” Journal of Ethnopharmacology, vol. 88, no. 1, pp. 63–68, 2003. View at Publisher · View at Google Scholar · View at Scopus
12. M. S. Al-Ghamdi, “The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa,” Journal of Ethnopharmacology, vol. 76, no. 1, pp. 45–48, 2001. View at Publisher · View at Google Scholar · View at Scopus
13. K. Vaidya and P. H. Kukarni, “A study of an Ayurvedic formula viz, ‘Jivak’,” Deerghaya International, vol. 7, pp. 20–222, 1991. View at Google Scholar
14. Pharmacopoeia Commission of PRC, Ed., Pharmacopoeia of the People’s Republic of China, vol. 1, Chemical Industry Press, Beijing, China, 2005.
15. S. S. Iddamaldeniya, N. Wickramasinghe, M. I. Thabrew, N. Ratnatunge, and M. G. Thammitiyagodage, “Protection against diethylnitrosoamine-induced hepatocarcinogenesis by an indigenous medicine comprised of Nigella sativa, Hemidesmus indicus and Smilax glabra: a preliminary study,” Journal of Carcinogenesis, vol. 2, no. 1, pp. 6–12, 2003. View at Publisher · View at Google Scholar · View at Scopus
16. S. R. Samarakoon, M. I. Thabrew, B. P. Galhena, D. de Silva, and K. Tennekoon, “A comparison of the cytotoxic potential of standardized aqueous and ethanolic extracts of a polyherbal mixture comprised of Nigella sativa (seeds), Hemidesmus indicus (roots) and Smilax glabra (rhizome),” Pharmacognosy Research, vol. 2, no. 6, pp. 335–342, 2010. View at Publisher · View at Google Scholar · View at Scopus
17. M. I. Thabrew, R. R. Mitry, M. A. Morsy, and R. D. Hughes, “Cytotoxic effects of a decoction of Nigella sativa, Hemidesmus indicus and Smilax glabra on human hepatoma HepG2 cells,” Life Sciences, vol. 77, no. 12, pp. 1319–1330, 2005. View at Publisher · View at Google Scholar · View at Scopus
18. M. A. Sabourdry, “Breeding and care of Laboratory animals,” WHO document (WHO/LAB/881), vol. 1, 1988.
19. “Guidelines for ethics review of research proposals involving animals in Sri Lanka,” Forum of Ethics Review Committee, 2009.
20. G. E. Paget and J. M. Barnes, Evaluation of Drug Activities: Pharmacometrics, Academic Press, New York, NY, USA, 1964.
21. C. A. Winter, E. A. Risley, and G. W. Nuss, “Carrageenan-induced edema in the hind paw of rat as an assay for anti-inflammatory activity,” Proceedings of the Society for Experimental Biology and Medicine, vol. 111, pp. 544–547, 1962. View at Google Scholar
22. P. Laupattarakasem, T. Wangsrimongkol, R. Surarit, and C. Hahnvajanawong, “In vitro and in vivo anti-inflammatory potential of Cryptolepis buchanani,” Journal of Ethnopharmacology, vol. 108, no. 3, pp. 349–354, 2006. View at Publisher · View at Google Scholar · View at Scopus
23. O. A. Olajide, J. M. Makinde, D. T. Okpako, and S. O. Awe, “Studies on the anti-inflammatory and related pharmacological properties of the aqueous extract of Bridelia ferruginea stem bark,” Journal of Ethnopharmacology, vol. 71, no. 1-2, pp. 153–160, 2000. View at Publisher · View at Google Scholar · View at Scopus
24. N. Ito, H. Tsuda, M. Tatematsu et al., “Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats—an approach for a new medium-term bioassay system,” Carcinogenesis, vol. 9, no. 3, pp. 387–394, 1988. View at Google Scholar · View at Scopus
25. K. Trnavsky, “Drug effects on connective tissue metabolism,” in Anti-Inflammatory Agents, R. A. Scherrer and M. W. Whitehouse, Eds., vol. 2, pp. 303–326, Academic Press, New York, NY, USA, 1974. View at Google Scholar
26. G. G. E. P. Souza and S. H. Ferreira, “Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity,” Agents and Actions, vol. 17, no. 1, pp. 97–103, 1985. View at Google Scholar · View at Scopus
27. M. Maccioni, L. E. Cabezas, and V. E. Rivero, “Effect of prostatein, the major protein produced by the rat ventral prostate, on phagocytic cell functions,” American Journal of Reproductive Immunology, vol. 50, no. 6, pp. 473–480, 2003. View at Publisher · View at Google Scholar · View at Scopus
28. V. P. Pereira Nacife, M. N. C. Soeiro, R. N. Gomes, H. D'Avila, H. Caire Castro-Faria Neto, and M. de Nazareth Leal Meirelles, “Morphological and biochemical characterization of macrophages activated by carrageenan and lipopolysaccharide in vivo,” Cell Structure and Function, vol. 29, no. 2, pp. 27–34, 2004. View at Publisher · View at Google Scholar · View at Scopus
29. O. A. Olajide, J. M. Makinde, D. T. Okpako, and S. O. Awe, “Studies on the anti-inflammatory and related pharmacological properties of the aqueous extract of Bridelia ferruginea stem bark,” Journal of Ethnopharmacology, vol. 71, no. 1-2, pp. 153–160, 2000. View at Publisher · View at Google Scholar · View at Scopus
30. R. M. Perez, S. Perez, M. A. Zavala, and M. Salazar, “Anti-inflammatory activity of the bark of Hippocratea excelsa,” Journal of Ethnopharmacology, vol. 47, no. 2, pp. 85–90, 1995. View at Publisher · View at Google Scholar · View at Scopus
31. F. Balkwill and A. Mantovani, “Inflammation and cancer: back to Virchow?” The Lancet, vol. 357, no. 9255, pp. 539–545, 2001. View at Publisher · View at Google Scholar · View at Scopus
32. F. Balkwill, K. A. Charles, and A. Mantovani, “Smoldering and polarized inflammation in the initiation and promotion of malignant disease,” Cancer Cell, vol. 7, no. 3, pp. 211–217, 2005. View at Publisher · View at Google Scholar · View at Scopus
33. M. Maccioni, L. E. Cabezas, and V. E. Rivero, “Effect of prostatein, the major protein produced by the rat ventral prostate, on phagocytic cell functions,” American Journal of Reproductive Immunology, vol. 50, no. 6, pp. 473–480, 2003. View at Publisher · View at Google Scholar · View at Scopus
34. N. M. Somnath, B. P. Sandeep, S. N. Nilophar, et al., “Evaluation of anti-nociceptive and anti-inflammatory activity of stems of Gynandropsis pentaphylla Linn,” International Journal of Green Pharmacy, vol. 2, no. 2, pp. 87–90, 2008. View at Publisher · View at Google Scholar
35. B. Warawanna, W. Wisut, R. Pornchai, et al., “Synthetic curcumin inhibits carrageenan-induced paw edema in rats,” Journal of Health Research, vol. 23, pp. 11–16, 2009. View at Google Scholar
36. R. Vinegar, W. Scheirber, and R. Hugo, “Biphasic development of carageenin edema in rat,” Journal of Pharmacology and Experimental Therapeutics, vol. 166, pp. 96–103, 1969. View at Google Scholar
37. J. B. Perianayagam, S. K. Sharma, and K. K. Pillai, “Anti-inflammatory activity of Trichodesma indicum root extract in experimental animals,” Journal of Ethnopharmacology, vol. 104, no. 3, pp. 410–414, 2006. View at Publisher · View at Google Scholar · View at Scopus
38. N. Kayagaki, N. Yamaguchi, M. Nakayama, E. Hiroshi, K. Okumura, and H. Yagita, “Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs,” Journal of Experimental Medicine, vol. 189, no. 9, pp. 1451–1460, 1999. View at Publisher · View at Google Scholar · View at Scopus
39. T. Toyonaga, O. Hino, S. Sugai et al., “Chronic active hepatitis in transgenic mice expressing interferon-γ in the liver,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 2, pp. 614–618, 1994. View at Google Scholar · View at Scopus
40. M. Mitsuru, N. Yasunari, S. Satoshi, T. Kurata, and S. Kaneko, “Interferon-γ-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine,” Laboratory Investigation, vol. 85, no. 5, pp. 655–663, 2005. View at Publisher · View at Google Scholar · View at Scopus
41. M. L. Salem, “Immunomodulatory and therapeutic properties of the Nigella sativa L. seed,” International Immunopharmacology, vol. 5, no. 13-14, pp. 1749–1770, 2005. View at Publisher · View at Google Scholar · View at Scopus
42. M. S. Mahmood, A. H. Gilani, A. Khwaja, A. Rashid, and M. K. Ashfaq, “The In vitro effect of aqueous extract of Nigella sativa seeds on nitric oxide production,” Phytotherapy Research, vol. 17, no. 8, pp. 921–924, 2003. View at Publisher · View at Google Scholar · View at Scopus
43. J. Wang, Y. Zhao, and Q. Xu, “Astilbin prevents concanavalin A-induced liver injury by reducing TNF-α production and T lymphocyte adhesion,” Journal of Pharmacy and Pharmacology, vol. 56, no. 4, pp. 495–502, 2004. View at Publisher · View at Google Scholar · View at Scopus
44. H. W. Yi, X. M. Lu, F. Fang, J. Wang, and Q. Xu, “Astilbin inhibits the adhesion of T lymphocytes via decreasing TNF-α and its associated MMP-9 activity and CD44 expression,” International Immunopharmacology, vol. 8, no. 10, pp. 1467–1474, 2008. View at Publisher · View at Google Scholar · View at Scopus
45. A. A. R. Sayed and M. Morcos, “Thymoquinone decreases AGE-induced NF-κB activation in proximal tubular epithelial cells,” Phytotherapy Research, vol. 21, no. 9, pp. 898–899, 2007. View at Publisher · View at Google Scholar · View at Scopus
46. M. A. El Gazzar, R. El Mezayen, M. R. Nicolls, and S. C. Dreskin, “Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation,” Biochimica et Biophysica Acta, vol. 1770, no. 4, pp. 556–564, 2007. View at Publisher · View at Google Scholar · View at Scopus
47. R. Gandhidasan and A. Thamaraichelvan, “Anti-inflammatory action of Lannea coromandelica by HRBC membrane stabilization,” Fitoterapia, vol. 62, no. 1, pp. 81–83, 1991. View at Google Scholar · View at Scopus
48. S. David, “Studies force new view on biology of flavonoids,” BioMed, vol. 541, pp. 737–787, 2007. View at Google Scholar
49. R. M. Jorge, J. P. V. Leite, A. B. Oliveira, et al., “Evalaution of antinociceptive, anti-inflammatory and anti-ulcerogenic activities of Maytenus illicifolia,” Journal of Ethnopharmacology, vol. 94, no. 1, pp. 93–100, 2004. View at Publisher · View at Google Scholar
50. R. M. J. Palmer, D. S. Ashton, and S. Moncada, “Vascular endothelial cells synthesize nitric oxide from L-arginine,” Nature, vol. 333, no. 6174, pp. 664–666, 1988. View at Google Scholar · View at Scopus
51. N. D. Kim, E. M. Kim, K. W. Kang, M. K. Cho, S. Y. Choi, and S. G. Kim, “Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase,” British Journal of Pharmacology, vol. 140, no. 4, pp. 661–670, 2003. View at Publisher · View at Google Scholar · View at Scopus
52. D. Miljkovic and V. Trajkovic, “Inducible nitric oxide synthase activation by interleukin-17,” Cytokine and Growth Factor Reviews, vol. 15, no. 1, pp. 21–32, 2004. View at Publisher · View at Google Scholar · View at Scopus
53. L. Sautebin, “Prostaglandins and nitric oxide as molecular targets for anti- inflammatory therapy,” Fitoterapia, vol. 71, no. 1, pp. S48–S57, 2000. View at Publisher · View at Google Scholar · View at Scopus
54. C. J. Meade, G. A. Turner, and P. E. Bateman, “The role of polyphosphoinositides and their breakdown products in A23187-induced release of arachidonic acid from rabbit polymorphonuclear leucocytes,” Biochemical Journal, vol. 238, no. 2, pp. 425–436, 1986. View at Google Scholar · View at Scopus
55. Y. Sakaguchi, H. Shirahase, A. Ichikawa, M. Kanda, Y. Nozaki, and Y. Uehara, “Effects of selective iNOS inhibition on type II collagen-induced arthritis in mice,” Life Sciences, vol. 75, no. 19, pp. 2257–2267, 2004. View at Publisher · View at Google Scholar · View at Scopus
56. C. A. Bradham, J. Plümpe, M. P. Manns, D. A. Brenner, and C. Trautwein, “Mechanisms of hepatic toxicity: I. TNF-induced liver injury,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 275, no. 3, pp. G387–G392, 1998. View at Google Scholar · View at Scopus
57. W. Andy, G. van Loo, K. Heyninck, and R. Beyaert, “Hepatic tumor necrosis factor signaling and nuclear factor-κB: effects on liver homeostasis and beyond,” Endocrine Reviews, vol. 28, no. 4, pp. 365–386, 2007. View at Publisher · View at Google Scholar · View at Scopus
58. Y. Yamada, E. M. Webber, I. Kirillova, J. J. Peschon, and N. Fausto, “Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor,” Hepatology, vol. 28, no. 4 I, pp. 959–970, 1998. View at Publisher · View at Google Scholar · View at Scopus
59. M. S. Hayden and S. Ghosh, “Signaling to NF-κB,” Genes and Development, vol. 18, no. 18, pp. 2195–2224, 2004. View at Publisher · View at Google Scholar · View at Scopus
60. H. L. Pahl, “Activators and target genes of Rel/NF-κB transcription factors,” Oncogene, vol. 18, no. 49, pp. 6853–6866, 1999. View at Google Scholar · View at Scopus
61. N. M. Chandler, J. J. Canete, and M. P. Callery, “Increased expression of NF-κB subunits in human pancreatic cancer cells,” Journal of Surgical Research, vol. 118, no. 1, pp. 9–14, 2004. View at Publisher · View at Google Scholar · View at Scopus